Endocrine Abstracts

Introduction: The global impact of COVID-19 has been unprecedented. Specific recommendations for the management of neuroendocrine disorders in the pandemic were rapidly released by Endocrine experts. To comply with COVID rules, NET patients, due to attend the endocrine unit in March 2020 for Somatostatin analogue therapy, were rapidly identified. 25 vulnerable patients had urgent domiciliary administration arranged. Other patients were taught to self-inject. Postal surveys wer...

Introduction: NETs are regarded as rare endocrine malignancies, which often present late. The COVID-19 pandemic may have affected this and patient care. The impact will have been felt in health service delivery and patient experiences. To understand NET patient perspectives and optimise care, we conducted a survey to review patient perception of: telemedicine-based care, delays to imaging, treatment, and the impact of COVID-19.Method: 70 NET patients tre...

Introduction: The COVID-19 pandemic has had a huge impact on the delivery of health services. Here we review the patient perspective, on rapid changes in treatment delivery of testosterone preparations instituted in the first wave of the pandemic.Methods: 49 hypogonadal male patients were identified as attenders to the Endocrine unit for Nebido™ injection. They were temporarily switched to testosterone gel to rapidly comply with COVID rules. 8 weeks...